BriLife

experimental COVID-19 vaccine

Facts

8 properties
Instance of
funded product
Subclass of
COVID-19 vaccine, viral vector vaccine, vaccine candidate[4][5][6]
Country of origin
Israel[7]
Route of administration
injection[8]
Vaccine for
COVID-19[9]
🏷️ Also known as
en BriLife en IIBR 100 en IIBR-100 en rVSV-SARS-CoV-2-S

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Subclass of 2
Country of origin 1
Developer 1
Funder 1
Manufacturer 1
Route of administration 1
Vaccine for 1
Press Enter · cited answer in seconds

Summary

BriLife is a funded product[1].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). BriLife. Retrieved November 7, 2026, from https://4ort.xyz/entity/brilife
MLA “BriLife.” 4ort.xyz Knowledge Graph, 4ort.xyz, 7 Nov. 2026, https://4ort.xyz/entity/brilife.
BibTeX @misc{4ortxyz_brilife_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{BriLife}}, year = {2026}, url = {https://4ort.xyz/entity/brilife}, note = {Accessed: 2026-11-07}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): BriLife — https://4ort.xyz/entity/brilife (retrieved 2026-11-07)

Canonical URL: https://4ort.xyz/entity/brilife · Last refreshed: